PC12 Cell Line <table class="infobox infobox-cell">Species </td>Tissue Origin </td>Cell Type </td>Key Marker Genes </td>Differentiation </td>Applications </td>Species </td>Tumor-derived </td>Differentiates </td>Dopaminergic </td>Cost </td>Genetic manipulation </td>Physiological relevance </td>
...
PC12 Cell Line <table class="infobox infobox-cell">Species </td>Tissue Origin </td>Cell Type </td>Key Marker Genes </td>Differentiation </td>Applications </td>Species </td>Tumor-derived </td>Differentiates </td>Dopaminergic </td>Cost </td>Genetic manipulation </td>Physiological relevance </td>
PC12 is a rat pheochromocytoma cell line established in 1976 by Greene and Tischler. This immortalized cell line derived from the adrenal medulla has become one of the most widely used models in neuroscience research for studying neuronal differentiation, neurotoxicity, and Parkinson's disease mechanisms.
Overview
Biology
Undifferentiated State In their undifferentiated state, PC12 cells:
Exhibit chromaffin-like phenotype
Express catecholamine biosynthesis enzymes (TH, DBH)
Contain dense-core vesicles with catecholamines
Possess some neuronal properties but do not fire action potentials
Divide every 2-3 days in culture
NGF-Induced Differentiation Upon treatment with nerve growth factor (NGF):
Phase 1 (Days 1-7) : Initial neurite outgrowth beginsPhase 2 (Days 7-14) : Extensive neurite extension and branchingPhase 3 (Day 14+) : Fully differentiated neuron-like cellsKey changes during differentiation:
Cessation of cell division
Extension of neurites (axons and dendrites)
Expression of neuronal markers (neurofilaments, MAP2)
Development of voltage-gated ion channels
Increased catecholamine synthesis
Formation of synaptic-like vesicles
Signaling Pathways
Mermaid diagram (expand to render)
Critical pathways include:
TrkA receptor activation : High-affinity NGF receptorMAPK/ERK pathway : Mediates differentiationPI3K/Akt pathway : Promotes survivalPLCgamma signaling : Calcium mobilizationApplications in Neurodegeneration Research
Parkinson's Disease Models PC12 cells are extensively used in PD research:
Alpha-Synuclein Toxicity Transfection with α-synuclein to model Lewy body formation
Studies on oxidative stress-induced aggregation
Drug screening for aggregation inhibitors
Neurotoxin Models MPP+ (MPTP metabolite) treatment
6-OHDA exposure
Rotenone application
All induce dopaminergic-like cell death
Mitochondrial Dysfunction Complex I inhibition studies
[ROS](/entities/reactive-oxygen-species) generation mechanisms](/entities)
[Apoptosis](/entities/apoptosis) pathways
Neuroprotective Drug Screening Testing compounds for dopaminergic protection
Antioxidant screening
[Autophagy](/entities/autophagy) modulators
Neurotoxicity Assessment PC12 cells serve as a model for:
Metal toxicity : Manganese, iron, copperEnvironmental toxins : Pesticides, industrial chemicalsDrug-induced neuropathy : Chemotherapy agents[Amyloid-beta](/proteins/amyloid-beta) toxicity : Relevance to [Alzheimer's disease](/diseases/alzheimers-disease)Comparison with Other Models
Key Protocols
Maintenance (Undifferentiated)
Culture medium: RPMI 1640 + 10% horse serum + 5% FBS
Incubator: 37°C, 5% CO2
Passaging: 70-80% confluency
No NGF added
Differentiation Protocol
Seed cells on poly-L-lysine coated plates
Replace with differentiation medium (RPMI + 1% horse serum)
Add NGF (50-100 ng/mL)
Refresh NGF every 2-3 days
Complete differentiation: 10-14 days
Neurotoxin Treatment (PD Model)
Differentiate cells for 10-14 days
Treat with toxin (e.g., 1-5 mM MPP+)
Assess viability at 24-72 hours
Measure: MTT reduction, ATP levels, ROS, apoptosis markers
Limitations
Tumor origin : May not fully recapitulate primary neuronsSpecies difference : Rat cells, not humanIncomplete differentiation : Never fully mature neuronsClonal variation : Different PC12 sublines varyCatecholamine phenotype : Adrenal rather than midbrain origin
Notable Studies
[Greene & Tischler, Establishment of a clonal line of rat adrenal pheochromocytoma cells (1976)](https://doi.org/10.1073/pnas.73.7.2424)
[Tischler et al., Protein kinase C activation and muscarinic receptor function (1990)](https://doi.org/10.1016/0014-5793(90)81071-X)
[Le et al., Alpha-synuclein aggregation in PC12 cells (2001)](https://doi.org/10.1002/j.1460-2075.2001.t01-001489.x)
[Jiang et al., Mitochondrial dysfunction in PC12 cells exposed to rotenone (2010)](https://doi.org/10.1016/j.jneuroim.2010.01.013)
Cross-References
[Tyrosine Hydrothase](/proteins/tyrosine-hydroxylase)
[Alpha-Synuclein](/proteins/alpha-synuclein)
[Parkinson's Disease](/diseases/parkinsons-disease)parkin)
[Nerve Growth Factor](/proteins/nerve-growth-factor)
[Dopaminergic Neurons](/cell-types/dopaminergic-neurons-hub)](/entities/neurons)
[Neurotoxicity Models](/experiments/neurotoxicity-models)
[SH-SY5Y Cell Line](/cell-types/sh-sy5y-cells)sh-sy5y)
[TrkA Receptor](/proteins/trka-receptor)
Brain Atlas Resources
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[Allen Cell Type Atlas](https://celltypes.brain-map.org/) - Single-cell expression data
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/) - Mouse brain reference data](/datasets/mouse-brain-atlas)
[Allen Human Brain Atlas](https://human.brain-map.org/microarray) - Gene expression data
See Also
[Parkinson's Disease](/diseases/parkinsons-disease)parkin)
[Dopaminergic Neurons](/cell-types/dopaminergic-neurons-hub)](/entities/neurons)
[SH-SY5Y Cell Line](/cell-types/sh-sy5y-cells)
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References fujita2020, Nerve growth factor signaling in PC12 cells (2020) (2020) [1](https://doi.org/10.1016/j.yexcr.2020.111890)
Show full description